Aikido pharma inc. provides update on its next-generation chemotherapeutic treatment dha-dfdc

New york, oct. 28, 2020 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today provided an update on its preclinical work on its next-generation chemotherapeutic, dha-dfdc, and the solid lipid nanoparticle (sln) drug delivery system to treat pancreatic cancer,...
DOMH Ratings Summary
DOMH Quant Ranking